D-Cycloserine ≥99% NMDA glycine site agonist
Informazioni su questo articolo
Partial agonist at the NMDA receptor glycine recognition site. Enhances learning and memory in vivo. Perfomance enhancer in a variety of cognitive models. Also available in simple stock solutions - add 1 ml of water to get an exact, ready-to-use concentration.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- Numero CAS:68-41-7
- Molecular Weight:102,09 g/mol
2 varianti
Product Details & Documents
Partial agonist at the NMDA receptor glycine recognition site. Enhances learning and memory in vivo. Perfomance enhancer in a variety of cognitive models. Also available in simple stock solutions - add 1 ml of water to get an exact, ready-to-use concentration.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- Numero CAS:68-41-7
- Molecular Weight:102,09 g/mol
Specifications for Product Family
Risultati dei test sulle specifiche
- Constituents::100% (R)-4-amino-1,2-oxazolidin-3-one



